| Literature DB >> 29936674 |
Motoharu Hamada1, Sayoko Doisaki1, Yusuke Okuno2, Hideki Muramatsu1, Asahito Hama1, Nozomu Kawashima1, Atsushi Narita1, Nobuhiro Nishio1,2, Kenichi Yoshida3, Hitoshi Kanno4, Atsushi Manabe5, Takashi Taga6, Yoshiyuki Takahashi1, Satoru Miyano7,8, Seishi Ogawa3, Seiji Kojima9.
Abstract
Congenital dyserythropoietic anemia (CDA) is a heterogeneous group of rare congenital disorders characterized by ineffective erythropoiesis and dysplastic changes in erythroblasts. Diagnosis of CDA is based primarily on the morphology of bone marrow erythroblasts; however, genetic tests have recently become more important. Here, we performed genetic analysis of 10 Japanese patients who had been diagnosed with CDA based on laboratory findings and morphological characteristics. We examined 10 CDA patients via central review of bone marrow morphology and genetic analysis for congenital bone marrow failure syndromes. Sanger sequencing for CDAN1, SEC23B, and KLF1 was performed for all patients. We performed whole-exome sequencing in patients without mutation in these genes. Three patients carried pathogenic CDAN1 mutations, whereas no SEC23B mutations were identified in our cohort. WES unexpectedly identified gene mutations known to cause congenital hemolytic anemia in two patients: canonical G6PD p.Val394Leu mutation and SPTA1 p.Arg28His mutation. Comprehensive genetic analysis is warranted for more effective diagnosis of patients with suspected CDA.Entities:
Keywords: Congenital dyserythropoietic anemia; Congenital hemolytic anemia; Whole-exome analysis
Mesh:
Year: 2018 PMID: 29936674 DOI: 10.1007/s12185-018-2482-7
Source DB: PubMed Journal: Int J Hematol ISSN: 0925-5710 Impact factor: 2.490